The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type

Table 4

The clinical significance of PRDM1 expression.

		Percent (%)	PRDM1 expression
			Negative	Positive
Patients	70
Male	39	55.71	30	9	0.578
Female	31	44.29	22	9
Age (year)	70
60	53	75.71	41	12	0.472
60	17	24.29	11	6
Angiocentric infiltration	70
With	27	38.57	24	3	0.027
Without	43	61.43	28	15
Necrosis	70
With	57	81.43	44	13	0.250
Without	13	18.57	8	5
Site	70
Nasal	57	81.43	39	18	0.046
Extranasal	13	18.57	13	0
B symptom	40
With	20	50.00	16	4	0.478
Without	20	50.00	14	6
Ann arbor Stage	57
I/II	22	38.60	10	12	0.003
III/IV	35	61.40	29	6
Outcome	40
Alive	14	35.00	7	7	0.006
Dead	26	65.00	23	3